Szot Matthew K 4
4 · Cadrenal Therapeutics, Inc. · Filed Oct 14, 2025
Insider Transaction Report
Form 4
Szot Matthew K
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-10-09$13.99/sh−1,693$23,685→ 15,333 total - Sale
Common Stock
2025-10-13$14.07/sh−1,800$25,326→ 13,533 total
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement.